DRUG-RESISTANT TUBERCULOSIS
Clinical trials for DRUG-RESISTANT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new DRUG-RESISTANT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for DRUG-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 9-Month pill regimen could tackle Drug-Resistant TB
Disease control Not yet recruitingThis phase 3 trial tests a 9-month, all-oral combination of four drugs (BLMZ) for people aged 12 and older with rifampicin-resistant tuberculosis. The goal is to see if this shorter regimen leads to a cure without the need for injections. Participants take the pills daily or week…
Matched conditions: DRUG-RESISTANT TUBERCULOSIS
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
TB stigma in the UK: a hidden barrier to care?
Knowledge-focused Not yet recruitingThis study looks at how people diagnosed with tuberculosis (TB) in rural and coastal areas of Southwest England experience stigma. Researchers will interview 20 patients to understand how stigma affects their lives and access to care. The goal is to develop better ways to support…
Matched conditions: DRUG-RESISTANT TUBERCULOSIS
Sponsor: Bournemouth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC